We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expert: Kennedy’s Death May Hurt Innovator Biologics Makers
Expert: Kennedy’s Death May Hurt Innovator Biologics Makers
August 26, 2009
Innovator biologic makers that sought a 10- to 12-year data exclusivity period may have to rebuild support in the Senate following the death of Sen. Edward Kennedy (D-Mass.) and the forthcoming change in leadership of the Senate Health, Education, Labor and Pensions Committee (HELP), an expert says.